Selection of human induced pluripotent stem cells lines optimization of cardiomyocytes differentiation in an integrated suspension microcarrier bioreactor

BACKGROUND: The production of large quantities of cardiomyocyte is essential for the needs of cellular therapies. This study describes the selection of a human-induced pluripotent cell (hiPSC) line suitable for production of cardiomyocytes in a fully integrated bioprocess of stem cell expansion and...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Stem Cell Res Ther
Autors principals: Laco, Filip, Lam, Alan Tin-Lun, Woo, Tsung-Liang, Tong, Gerine, Ho, Valerie, Soong, Poh-Loong, Grishina, Elina, Lin, Kun-Han, Reuveny, Shaul, Oh, Steve Kah-Weng
Format: Artigo
Idioma:Inglês
Publicat: BioMed Central 2020
Matèries:
Research
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC7076930/
https://ncbi.nlm.nih.gov/pubmed/32183888
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s13287-020-01618-6
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars